Abstract
The high cost of prescription drugs in the United States is due in large part to the monopoly power granted to manufacturers through the drug and patent approval processes, together with restrictions that limit the ability of payers to negotiate prices, researchers have concluded in a study in JAMA .1 Currently, per capita prescription drug spending in the US is the highest in the world, reaching $858 (£660; €760) in 2013, more than twice the average of $400 in 19 other industrialized nations. In the new study, Aaron S Kesselheim, of Harvard Medical …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.